COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections

[1]  A. Banga,et al.  CARE Score on Chest Radiograph at Diagnosis Predicts Early and Late Outcomes Among Lung Transplant Patients with COVID-19 , 2022, The Journal of Heart and Lung Transplantation.

[2]  M. Loebe,et al.  Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic , 2021, American Journal of Transplantation.

[3]  F. Torres,et al.  Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐19 , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[4]  Qulu Zheng,et al.  Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. , 2021, JAMA internal medicine.

[5]  Casey N. Ta,et al.  A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness , 2021, medRxiv.

[6]  D. Fisman,et al.  Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada , 2021, Canadian Medical Association Journal.

[7]  Song Zhang,et al.  Post‐infection pulmonary sequelae after COVID‐19 among patients with lung transplantation , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  S. Scharringa,et al.  Vaccination and their importance for lung transplant recipients in a COVID-19 world , 2021, Expert review of clinical pharmacology.

[9]  S. Little,et al.  Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  P. Shah,et al.  Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients , 2021, Transplantation.

[11]  S. Husain,et al.  Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City , 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[12]  R. Sindhi,et al.  T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study. , 2021, medRxiv.

[13]  F. Torres,et al.  Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19 , 2021, The Journal of Heart and Lung Transplantation.

[14]  D. Segev,et al.  Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. , 2021, JAMA.

[15]  G. Rahav,et al.  BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response , 2021, The Journal of Heart and Lung Transplantation.

[16]  D. Segev,et al.  Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. , 2021, JAMA.

[17]  L. Braun-Parvez,et al.  Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients , 2021, medRxiv.

[18]  Jonathan C. Brown,et al.  Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine , 2021, The Lancet.

[19]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.